Trilogy International Partners Inc T.TRL.WT.A

Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.

TSXV:TRL.H - Post by User

Trilogy International Partners Inc

Bullboard Posts

Comment by FinalAnalyticon Mar 03, 2016 7:32pm

102 Views

Post# 24620032

RE:RE:RE:That was a great call!

WCoyote wrote:

eSnowden wrote:
Acerus has received no bids since the JPM conference, Rossi said that himself. How do you get a partner with no bids? And although they EXPECT an upfront payment, who in their right mind would pay that given actual precript. sales were $100k. Also, Midcap wants full repayment 1/2016 and cash raise is expected q4 2015....how does that work on a 9 cent stock?

Are you a little slow? I'd use the 'R' word, but that might be insulting to some.

They have not received any bids yet, because they are not at that stage yet in the process. Did you not listen, or did you only hear what you wanted to hear? This is being worked though a 3rd party. Once the bids have been collected by the close date, they will be vetted and passed on the Acerus for their consideration.

Also, the $100K was their portion of the prescription sales. Not only does Endo pay them for product, they kick-back a small percentage of the actual sales. Again, you either have a listening problem or a learning problem. This has been known ever since they first announced the partnership.

We are in 2016 already, not 2015. There may not need to be a cash raise at all, I am sure everyone else heard that too - except you apparently. Again, you were not listening. The cash raise (whether another loan or a PP) would only be needed as a worst case situation.

I'm not going to bother with you anymore. Dealing with you is frustrating and annoying as you get everything wrong, then spout out some negative cr@p about it.